在今年4月25日以“宝宝健康——从接种疫苗开始”为主题的第28个全国儿童预防接种日来临之际，由原卫生部疾控局指导，中国健康教育中心（卫生部新闻宣传中心）联合中华预防医学会、中华医学会儿科分会共同举办的“爱在百天——中国宝贝健康行动”肺炎链球菌性疾病健康教育与健康传播项目于20日在北京启动。

    In April 25 this year"Baby health, starting from the vaccination"As the theme of a national child vaccination day approaching 28,By the guidance of the ministry of health disease control bureau,Centre for health education in China(The ministry of health center news propaganda)Combined the Chinese preventive medicine association/The Chinese medical association of pediatrics branch held together"Love in the one hundred - day Chinese baby health action"Pneumococcal disease health education and health communication project launched in Beijing on May 20.

    中国疾病预防控制中心流行病学首席科学家曾光教授强调，我国目前对以肺炎链球菌性疾病为代表的严重威胁儿童生命和健康的感染性疾病的重视程度，尚待加强。肺炎位列我国五岁以下儿童死因的第二位，而在各种肺炎之中，大约有50%的重症肺炎由肺炎链球菌引起。

    The Chinese center for disease control and prevention epidemiological chief scientist professor zeng guang,At present to represented by pneumococcal disease serious threat to children's lives and health of infectious diseases of importance,Is yet to be strengthened.Pneumonia is the second leading cause of death among children under five years old in China,And in all sorts of pneumonia,About 50% of severe pneumonia caused by streptococcus pneumoniae.

    首都医科大学教授、博士生导师杨永弘强调，抗生素耐药问题是目前儿童肺炎链球菌疾病治疗所面临的一个全球性的、急剧发展的问题。我国肺炎链球菌抗生素耐药形势严峻，并呈现逐年上升的趋势。由于肺炎链球菌有很多种，其中分布最广、引起疾病最多的一些血清型对某些抗生素耐药性已达到80%以上，甚至100%，导致治疗难度很大。耐药致病菌导致的感染往往是致命的。耐药所致的治疗无效或治疗周期延长、治疗费用增加等，也给患者及家庭带来了沉重负担。全球很多国家的经验表明，肺炎球菌结合疫苗具有良好的免疫原性，接种疫苗是降低肺炎链球菌耐药率的有效手段之一。 （记者张秀兰）

    The capital university of medical sciences professor/Doctoral tutor Yang Yonghong emphasis,Antibiotic resistance problem is the pneumococcal disease treatment to children facing a global/Rapidly development.Pneumococcal grim situation of antibiotic resistance in China,And showed a trend of rising year by year.Because there are many kinds of streptococcus pneumoniae,One of the most widely distributed/The some serotype of most diseases caused by resistance to some antibiotics has reached more than 80%,Even a 100%,Result in treatment difficult.Drug-resistant pathogenic bacteria cause the infection is often deadly.Drug resistance caused by treatment is invalid or extend the treatment cycle/Treatment costs increase, etc,Also brought heavy burden to patients and families.Experience has shown that in many countries around the world,Pneumococcal conjugate vaccine has good immunogenicity,Vaccination is one of the effective means of reducing pneumococcal ni. (The reporter Zhang Xiulan)